Skip to main content
61°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Organon & Co.
(NY:
OGN
)
22.36
+1.47 (+7.04%)
Official Closing Price
Updated: 7:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co.
< Previous
1
2
3
4
5
6
7
8
9
Next >
'FTX Users May Seek DeFi Alternatives,' Interview With Origin Protocol's Andra Nicolau
November 28, 2022
In a risk-off environment where cryptocurrency has plummeted to a fraction of its previous valuation, it’s no secret raising capital in 2022 has become a challenge for startups and industry behemoths...
Via
Benzinga
Organon To Present at the Piper Sandler 34th Annual Healthcare Conference
November 15, 2022
From
Organon & Co.
Via
Business Wire
10 Spin-Off Stocks That Pay Dividends
November 07, 2022
10 spin-offs from recent years that now pay dividends after being separated from their parent companies.
Via
Talk Markets
Organon Reports Better Than Expected Q3 Earnings
November 03, 2022
Via
Benzinga
Recap: Organon Q3 Earnings
November 03, 2022
Organon (NYSE:OGN) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Organon beat estimated earnings by...
Via
Benzinga
Organon Expects Lower EBITDA Margin For FY22, Clocks Mixed Q2 Earnings
August 04, 2022
Via
Benzinga
Organon Reports Results for the Third Quarter Ended September 30, 2022
November 03, 2022
From
Organon & Co.
Via
Business Wire
Looking Into Organon's Recent Short Interest
November 02, 2022
Organon's (NYSE:OGN) short percent of float has fallen 4.48% since its last report. The company recently reported that it has 5.78 million shares sold short, which is 2.56% of all regular shares that...
Via
Benzinga
Origin Protocol Building DeFi & NFTs In The Bear: Interview With Co-Founder Joshua Fraser
November 01, 2022
Blockchain startups raised an aggregate of billions of dollars through the bull market, but it’s no secret those days are at least temporarily halted. For most DeFi protocols and almost every NFT...
Via
Benzinga
Organon To Report Third Quarter Results and Host Conference Call on November 3, 2022
October 20, 2022
From
Organon & Co.
Via
Business Wire
Beat the Dow Jones With This Unstoppable Dividend Stock
October 19, 2022
This pharmaceutical stock combines strong financials with an above-average dividend.
Via
The Motley Fool
Roofstock onChain Sells 1st Real Estate Property On Ethereum, Powered by Origin Protocol NFTs and Teller DeFi
October 18, 2022
Leading real estate investment platform Roofstock announced its 1st property sale via Ethereum’s blockchain, enabled by Roofstock onChain (ROC), its web3 subsidiary. Roofstock onChain is a real estate...
Via
Benzinga
Jim Cramer Says People Are Betting Against Stock Up 84% This Year: It Could Be An 'Up Big, Down Big Situation'
October 18, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he can’t recommend Dice Therapeutics Inc (NASDAQ: DICE) as the company is "losing money hand over fist."
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 14, 2022
October 14, 2022
Upgrades
Via
Benzinga
121 Stocks That Hit Their 52-Week Low
October 14, 2022
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows.
Via
Benzinga
Netflix To Gain Around 8%? Plus This Analyst Slashes PT On Five9 By About 50%
October 14, 2022
UBS boosted Netflix, Inc. (NASDAQ: NFLX) price target from $198 to $250. Netflix shares rose 5.3% to close at $232.51 on Thursday.
Via
Benzinga
No Need To Call A Broker: Real Estate NFTs Let Homeowners Cut Out The Middleman Via Roofstock and Origin Protocol
October 06, 2022
The $11 trillion real estate market remains a much talked about industry for streamlining access, reducing transaction friction, and democratizing ownership. Real estate technology company Roofstock...
Via
Benzinga
How Is The Market Feeling About Organon?
October 06, 2022
Organon's (NYSE:OGN) short percent of float has risen 11.91% since its last report. The company recently reported that it has 5.94 million shares sold short, which is 2.63% of all regular shares that...
Via
Benzinga
After FDA Regulatory Setback, Penny Stock ObsEva Cuts 70% Of Its Staff
September 13, 2022
Via
Benzinga
This Analyst Predicts $396 For Eli Lilly, Plus Raymond James Slashes PT On This Stock By Over 73%
September 06, 2022
Raymond James cut the price target for PolyPid Ltd. (NASDAQ: PYPD) from $15 to $4. PolyPid shares fell 7.7% to $1.32 in pre-market trading.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
September 07, 2022
On Wednesday, 297 companies achieved new lows for the year.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
September 06, 2022
Upgrades
Via
Benzinga
This Women Health Stock Gets Analyst Downgrade On 'Approvability Issues, Restructuring'
August 30, 2022
Via
Benzinga
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 17, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 31, 2022
On Wednesday, 238 companies achieved new lows for the year.
Via
Benzinga
Samsung Bioepis and Organon Announce FDA Approval of Citrate-Free High-Concentration HUMIRA® Biosimilar HADLIMA™ (adalimumab-bwwd)
August 17, 2022
From
Organon & Co.
Via
Business Wire
A Look Into Healthcare Sector Value Stocks
August 15, 2022
Understanding Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022
August 05, 2022
Upgrades
Via
Benzinga
Organon: Q2 Earnings Insights
August 04, 2022
Organon (NYSE:OGN) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Organon reported in-line EPS of $1.25...
Via
Benzinga
Organon Reports Results for the Second Quarter Ended June 30, 2022
August 04, 2022
From
Organon & Co.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.